Showing results (501-510 of 844) with videos related to
Sort By:
Pageof 85
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2005
Are all high-grade breast cancers with no steroid receptor hormone expression alike? The special case of the medullary phenotypeL Orlando, G Renne, A Rocca, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer ResearchM Borner, M Bacchi, A Goldhirsch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Timing of baseline quality of life assessment in an international adjuvant breast cancer trial: its effect on patient self-estimation. The International Breast Cancer Study GroupC Hürny, J Bernhard, A Coates, et al.European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Pre-operative chemotherapy and radiotherapy in breast cancerM Colleoni, F Nole, I Minchella, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1996
First-line fadrozole HCI (CGS 16949A) versus tamoxifen in postmenopausal women with advanced breast cancer. Prospective randomised trial of the Swiss Group for Clinical Cancer Research SAKK 20/88B Thürlimann, K Beretta, M Bacchi, et al.Breast Cancer Research and Treatment|September 6, 2011
The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopauseJacquie Chirgwin, Zhuoxin Sun, Ian Smith, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?J Bernhard, B Thürlimann, S F Schmitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Quality-of-life-adjusted survival analysis of interferon alfa-2b treatment for advanced follicular lymphoma: an aid to clinical decision makingB F Cole, P Solal-Céligny, R D Gelber, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 28, 2004
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trialA D Roth, R Maibach, N Fazio, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2006
When can a second conservative approach be considered for ipsilateral breast tumour recurrence?O Gentilini, E Botteri, N Rotmensz, et al.Pageof 85